Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 750 mg/150 mL (25mg/5mL), Rx Only, Distributed by: NextWave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc, New York, NY 10017 Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852 (NDC 24478-205-25).
Published March 29, 2017 · Recall initiated: March 7, 2017
Summary
FDA records drug Class III recall D-0608-2017, published March 29, 2017 and initiated March 7, 2017. Recalling firm: Pfizer Inc; Status: Terminated; Reported quantity: 11,862 units; Lot: Lot #: 03216026A, Exp. 02/18. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pfizer Inc
- Distributor
- Nationwide within US
- Lot
- Lot #: 03216026A, Exp. 02/18
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAQuillivant XR (methylphenidate HCl) for extended-release oral suspension, 300 mg/60 mL (25mg/5mL), Rx Only,March 29, 2017
- FDAQuillivant XR (methylphenidate HCl) for extended-release oral suspension, 900 mg/180 mL (25mg/5mL), Rx Only,March 29, 2017
- FDAATENOLOL Tablets, USP, 50 mg, 30-count bottle, Rx only, Distributed by: The Kroger Co., 1014 Vine Street,March 29, 2017
- FDAFamciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for: AvKARE, Inc.,March 29, 2017
- FDAATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottlesMarch 29, 2017
- FDANorpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottlesJune 26, 2013
Questions about this recall
Was Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 750 mg/150 mL (25mg/5mL), Rx Only, Distributed by: NextWave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc, New York, NY 10017 Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852 (NDC 24478-205-25). recalled?
Yes. FDA published recall D-0608-2017 on March 29, 2017. Reported hazard: Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.
What should I do if I have this product?
Voluntary: Firm initiated · Letter